Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kobinger GP"'
Autor:
de La Vega MA; Département de microbiologie-infectiologie et immunologie, Université Laval, Quebec, QC G1V 4G2, Canada., Kobinger GP; Département de microbiologie-infectiologie et immunologie, Université Laval, Quebec, QC G1V 4G2, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Electronic address: gary.kobinger@crchudequebec.ulaval.ca.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Apr; Vol. 20 (4), pp. 388-389. Date of Electronic Publication: 2020 Jan 14.
Autor:
Tebas P; University of Pennsylvania, Philadelphia., Kraynyak KA; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Patel A; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Maslow JN; GeneOne Life Science, Gangnam-Gu, Seoul, Korea., Morrow MP; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Sylvester AJ; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Knoblock D; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Gillespie E; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Amante D; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Racine T; Université Laval, Quebec City, Quebec, Canada., McMullan T; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Jeong M; GeneOne Life Science, Gangnam-Gu, Seoul, Korea., Roberts CC; GeneOne Life Science, Gangnam-Gu, Seoul, Korea., Park YK; GeneOne Life Science, Gangnam-Gu, Seoul, Korea., Boyer J; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Broderick KE; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Kobinger GP; Université Laval, Quebec City, Quebec, Canada., Bagarazzi M; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Weiner DB; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Sardesai NY; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., White SM; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Jul 02; Vol. 220 (3), pp. 400-410.
Autor:
Patel A; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Reuschel EL; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Kraynyak KA; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Park DH; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Scott VL; College of Osteopathic Medicine, William Carey University, Hattiesburg, Mississippi., Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Amante D; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Wise MC; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Keaton AA; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Villarreal DO; University of Pennsylvania, Philadelphia., Walters J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Muthumani K; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Shedlock DJ; University of Pennsylvania, Philadelphia., de La Vega MA; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Plyler R; University of Pennsylvania, Philadelphia., Boyer J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Broderick KE; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Yan J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Khan AS; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Jones S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Bello A; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Soule G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Tran KN; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., He S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Tierney K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Kobinger GP; University of Pennsylvania, Philadelphia.; Université Laval, Québec, Canada., Sardesai NY; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Weiner DB; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Jan 29; Vol. 219 (4), pp. 544-555.
Autor:
Wong G; a Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, Shenzhen Key Laboratory of Pathogen and Immunity , Shenzhen Third People's Hospital , Shenzhen , China.; b CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology , Chinese Academy of Sciences , Beijing , China.; c National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , MB , Canada.; d Department of Medical Microbiology , University of Manitoba , Winnipeg , MB , Canada., Mendoza EJ; c National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , MB , Canada.; e Department of Immunology , University of Manitoba , Winnipeg , MB , Canada., Plummer FA; d Department of Medical Microbiology , University of Manitoba , Winnipeg , MB , Canada., Gao GF; a Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, Shenzhen Key Laboratory of Pathogen and Immunity , Shenzhen Third People's Hospital , Shenzhen , China.; f National Institute for Viral Disease Control and Prevention , Chinese Center for Disease Control and Prevention (China CDC) , Beijing , China., Kobinger GP; c National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , MB , Canada.; d Department of Medical Microbiology , University of Manitoba , Winnipeg , MB , Canada.; e Department of Immunology , University of Manitoba , Winnipeg , MB , Canada.; g Department of Pathology and Laboratory Medicine , University of Pennsylvania School of Medicine , Philadelphia , PA , USA.; h Département de microbiologie-infectiologie et d'immunologie , Université Laval , Québec , Canada., Qiu X; c National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , MB , Canada.; d Department of Medical Microbiology , University of Manitoba , Winnipeg , MB , Canada.
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2018 Feb; Vol. 18 (2), pp. 159-173. Date of Electronic Publication: 2017 Nov 17.
Autor:
Kozak RA; a Special Pathogens Program, National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , Canada.; b Department of Medical Microbiology , University of Manitoba , Winnipeg , Canada., Kobinger GP; a Special Pathogens Program, National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , Canada.; b Department of Medical Microbiology , University of Manitoba , Winnipeg , Canada.; c Department of Pathology and Laboratory Medicine , University of Pennsylvania School of Medicine , Philadelphia , PA , USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2016 Sep; Vol. 15 (9), pp. 1093-100. Date of Electronic Publication: 2016 Apr 12.
Autor:
Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada Department of Medical Microbiology., Richardson JS; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Pillet S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Patel A; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada Department of Medical Microbiology., Soule G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada., Ennis J; Defyrus, Toronto, Canada., Turner J; Defyrus, Toronto, Canada., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada Department of Medical Microbiology., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada Department of Medical Microbiology Department of Immunology, University of Manitoba, Winnipeg Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2015 Oct 01; Vol. 212 Suppl 2, pp. S379-83. Date of Electronic Publication: 2015 May 09.
Autor:
Choi JH; †Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States., Jonsson-Schmunk K; †Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States., Qiu X; §Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada., Shedlock DJ; ∥Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States., Strong J; §Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada., Xu JX; †Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States., Michie KL; ⊥The University of Texas College of Natural Sciences Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas 78712, United States., Audet J; §Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada., Fernando L; §Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada., Myers MJ; †Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States., Weiner D; ∥Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States., Bajrovic I; #Department of Biochemistry, College of Natural Sciences, The University of Texas at Austin, Austin, Texas 78712, United States., Tran LQ; †Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States., Wong G; §Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada., Bello A; §Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada., Kobinger GP; §Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.; ∥Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States., Schafer SC; †Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States., Croyle MA; †Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States.; ⊥The University of Texas College of Natural Sciences Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas 78712, United States.; ¶Center for Infectious Disease, The University of Texas at Austin, Austin, Texas 78712, United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2015 Aug 03; Vol. 12 (8), pp. 2712-31. Date of Electronic Publication: 2014 Nov 14.
Autor:
Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada., Richardson JS; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada., Cutts T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada; Department of Immunology, University of Manitoba, Winnipeg, MB, Canada; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Electronic address: gary.kobinger@phac-aspc.gc.ca.
Publikováno v:
Antiviral research [Antiviral Res] 2015 Apr; Vol. 116, pp. 17-9. Date of Electronic Publication: 2015 Jan 14.
Autor:
Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada., Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada., Fernando L; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada., Fausther-Bovendo H; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada., Alimonti JB; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada; Department of Immunology, University of Manitoba, Winnipeg, MB, Canada; Department of Pathology and Laboratory Medicine, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2 Canada. Electronic address: xiangguo.qiu@phac-aspc.gc.ca.
Publikováno v:
Vaccine [Vaccine] 2014 Sep 29; Vol. 32 (43), pp. 5722-9. Date of Electronic Publication: 2014 Aug 27.
Autor:
Richardson JS; Special Pathogens Department, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Pillet S, Bello AJ, Kobinger GP
Publikováno v:
Journal of virology [J Virol] 2013 Apr; Vol. 87 (7), pp. 3668-77. Date of Electronic Publication: 2013 Jan 09.